Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04159155
Title A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer (CAN-STAMP)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto

endometrial clear cell adenocarcinoma

endometrial serous adenocarcinoma


Carboplatin + Cisplatin + Paclitaxel

Carboplatin + Niraparib + Paclitaxel

Carboplatin + Paclitaxel

Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST